Drug
Oxycodone 10mg
Oxycodone 10mg is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_4
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (66.7%)
N/A1 (33.3%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_4
Combined Effect of Pregabalin and Oxycodone, and Lacosamide and Oxycodone, on Breathing
NCT05598905
completedphase_4
Oxycodone (10, 20 mg) in a Postoperative Dressing
NCT06142591
completednot_applicable
Comparison of Effects of Oxycodone and Sufentanil on Cardiovascular Stress Induced by Tracheal Intubation in the Patients With Coronary Heart Disease Undergoing Major Noncardiac Surgery
NCT04121416
Clinical Trials (3)
Showing 3 of 3 trials
NCT05598905Phase 4
Combined Effect of Pregabalin and Oxycodone, and Lacosamide and Oxycodone, on Breathing
NCT06142591Phase 4
Oxycodone (10, 20 mg) in a Postoperative Dressing
NCT04121416Not Applicable
Comparison of Effects of Oxycodone and Sufentanil on Cardiovascular Stress Induced by Tracheal Intubation in the Patients With Coronary Heart Disease Undergoing Major Noncardiac Surgery
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3